Release Notes: Version 20190408

DateApril 8, 2019 
AccessTerminology Gateway
Release TypeMaintenance Release

About this maintenance release 

This release includes the Canadian Clinical Drug Data Set files (version 20190408).  

The Editorial Guidelines and the Technical Specification have not been revised with this release. 

The Canadian Clinical Drug Data Set is available for browsing and download via the Infoway Terminology Gateway.  

Supporting general information can be found on Infoway Canadian Clinical Drug Data Set InfoCentral page.  

General Notes

The following files will be available as full release files within this version:

  • Manufactured Product,
  • Non-proprietary Therapeutic Product,
  • Therapeutic Moiety,
  • Manufactured Product, Non-proprietary Therapeutic Product, Therapeutic Product Relationship,
  • Special Groupings, 
  • Coded Attribute, and
  • Device Non-proprietary Therapeutic Product.

The 'Full" release contains one entry for every concept that has ever been released and new content added for that release.   New content added for a specific release may at times include “Inactive” content.

NOTE:  The “Delta" release which is intended to contain only those concepts that have been added or changed since the previous release will be considered for a future enhancement at a later date.  

This release continues to add additional content from the DPD and includes most of the top 250 moieties and approximately 95% of the DPD content in scope for CCDD.  

The table below provides the number of concepts within each CCDD file for this release.

April 2019 CCDD Files
Number of Concepts
Types of Changes in this release
Therapeutic Moiety Full Release1359

44 additions

1 deprecated concept (see TM change below)

Non-proprietary Therapeutic Product Full Release3935

123 additions

6 status change from (5 from active to inactive and 1 inactive to active)

1 status change from active to deprecated (see NTP change below)

20 status date changes with no change of status

Manufactured Product Full Release10910

367 additions

  • 48 MPs for existing NTPs
  • 319 MPs for new TMs

Formal name changes made:

  • 21 DPD company changes
  • 44 DPD company name changes
  • 8 DPD products with name change and company change
  • 16 DPD product name changes
  • 2 DPD changes in dose form (see MP change details below)

40 status changes from active to inactive

4 status changes from inactive to active

5 status date changes (no change of status)

Manufactured Product, Non-proprietary Therapeutic Product, Therapeutic Moiety Relationship

10907

Includes concept additions and changes as above

Deprecated concepts have been excluded.

Device Non-proprietary Therapeutic Product3no change
Special Groupings1815

31 additional entries due to new concepts

Includes concept additions and changes as above

Coded Attributes7

no change

TM change

Since Glycopyrronium and Glycopyrrolate are synonyms, the following concept has been deprecated;  8001659 - glycopyrrolate.  All existing NTPs and MPs are now associated in the relationship file with the following TM;  8001082 - glycopyrronium.  The existing NTP and MP formal names with the active ingredient of glycopyrrolate have not changed in order to align with current product labels.

MP Changes

The following MP concepts had a change in dose form.

mp_code April Release

mp_formal_name April Release

mp_code March Release

mp_formal_name March Release

00443832

DEPAKENE (valproic acid (sodium valproate) 250 mg per 5 mL syrup) BGP PHARMA ULC

00443832

DEPAKENE (valproic acid (sodium valproate) 250 mg per 5 mL oral solution) BGP PHARMA ULC

02320959BENYLIN EXTRA STRENGTH MUCUS & PHLEGM PLUS COUGH CONTROL (dextromethorphan hydrobromide 15 mg per 5 mL and guaifenesin 200 mg per 5 mL and menthol 15 mg per 5 mL syrup) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC02320959BENYLIN EXTRA STRENGTH MUCUS & PHLEGM PLUS COUGH CONTROL (dextromethorphan hydrobromide 15 mg per 5 mL and guaifenesin 200 mg per 5 mL and menthol 15 mg per 5 mL oral solution) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC

NTP Change

Due to the MP change to MP code 02320959 as described above, the following NTP concept is no longer needed and has been deprecated; 

9004569; dextromethorphan hydrobromide 15 mg per 5 mL and guaifenesin 200 mg per 5 mL and menthol 15 mg per 5 mL oral solution.

Questions, Concerns, Changes

Questions and concerns and suggestions for future consideration are welcomed and should be sent by e-mail at [email protected]

Please note that to access InfoCentral, you must have an Infoway login.  If you have any questions about any of our standards or products, please contact the Infodesk Desk at: 

Toll Free #: 1-877-595-3417 or 416-595-3417 

E-mail: [email protected] 

  • No labels